Brian Meshkin

Genotrim™, a DNA-customized nutrigenomic product, targets genetic factors of obesity: Hypothesizing a dopamine–glucose correlation demonstrating reward deficiency syndrome (RDS)

Kenneth Blum, Thomas J.H. Chen, Brian Meshkin et al. · Medical Hypotheses · 2006 · 78 citations

Life Sciences, Biotechnology, Genetics +12

Reward deficiency syndrome in obesity: A preliminary cross-sectional trial with a genotrim variant

Kenneth Blum, Thomas J.H. Chen, Brian Meshkin et al. · Advances in Therapy · 2006 · 58 citations

Medicine, Endocrinology, Genetics +12

Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: A hypothesis

Kenneth Blum, Thomas J.H. Chen, Brian Meshkin et al. · Medical Hypotheses · 2007 · 50 citations

Life Sciences, Pharmacology, Psychology +14

Gene Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome

Thomas J.H. Chen, Kenneth Blum, Roger L. Waite et al. · Advances in Therapy · 2007 · 33 citations

Medicine, Pharmacology, Psychiatry +17

Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting

Eric R. Braverman, Thomas J.H. Chen, John Schoolfield et al. · Advances in Therapy · 2006 · 31 citations

Medicine, Neurology, Neuroscience +10